In
what may be construed as a breakthrough in inhalation
anesthesia market, Baxter International Incorporation, a medical products
manufacturer, has collaborated with Dorizoe Lifesciences Limited, a CRO firm,
to develop over twenty generic injectable high-quality products comprising
oncolytics, cardiovascular medicines, and anti-infectives. Baxter had already
made it to the headlines earlier this year for its acquisition of Claris
injectables limited, a key player across inhalation anesthesia industry, in a
bid to expand its geographical presence.
Apparently,
Claris’ inclusion in its acquisition fold would help the firm consolidate their
portfolio of anesthesia and analgesics drug products. Baxter’s unpretentious
but powerful penetration in inhalation anesthesia industry underlines its
commitment toward the medical and pharma verticals. Driven by the commendable
efforts of medical companies and the robust prevalence of chronic ailments
leading to the subsequent demand for anesthetics, inhalation anesthesia market
size was pegged at USD 1,285.8 million in 2016.
The
product landscape of inhalation anesthesia market comprises isoflurane,
sevoflurane, and desflurane – essential anesthetics used during crucial
surgeries. Sevoflurane among these, is renown to have contributed significantly
towards inhalation anesthesia industry revenue in 2016. Subject to favorable
product features such as low flammability and intrinsic stability, sevoflurane
inhalation anesthesia market share is set to witness a commendable expansion
over the next few years. Its counterpart – isoflurane is mostly preferred in
neurosurgeries due to its ability to potentiate muscle relaxant activity and
assist the expansion of systemic vessels.
Considering
the rising prevalence of chronic diseases such as cancer across the U.S., in
tandem with the high-grade healthcare infrastructure and medical care
expenditure of the country, it comes as no surprise that the United States is
one of most remunerative avenues for inhalation anesthesia market. Estimates
claim that the U.S. dominated the regional market share in 2016, driven by the
surging product deployment in plastic surgeries and the growing prevalence of
chronic lower respiratory ailments.
Browse key industry insights spread across 130 pages with 168 market data tables & 9 figures & charts
from the report
Inhalation Anesthesia
Market in detail along with the table of
contents:
Pertaining
to the widespread applications of the product, inhalation anesthesia market has
successfully established its presence across many other geographies across the
globe, apart from the U.S. Europe inhalation anesthesia industry size for
instance, impelled by the thriving economies of UK and Germany, is likely to
chart out a profitable growth path in the years ahead. UK, in particular, will
register a substantial growth rate over 2017-2024, given the rising prevalence
of cancer and the rapidly increasing rate of surgical procedures.
Germany
apparently, accounted for the highest share in the Europe market, driven by the
growing geriatric population suffering from chronic ailments. In fact, as per
estimates, cancer and cardiovascular disorders account for more than 66% of
deaths in the country – a factor which
is slated to upsurge the demand for anesthesia in surgeries, inherently
propelling Germany inhalation anesthesia industry size.
Inhalation
anesthesia market, touted to be one of most profitable business spheres of
recent times, has its share of restraints, one of principal ones being, the
ill-effects of anesthetic products. Pertaining to the same, companies have been
brainstorming ways to innovate contemporary products as per the illness and the
level of its seriousness in question.
In
essence, the undertaking of strategic initiatives and the growing R&D
funding are expected to successfully complement inhalation anesthesia market
outlook in the forthcoming years. If estimates are to be believed, this
business vertical is anticipated to generate a target valuation exceeding USD
1.6 billion by 2024.
Browse
Related Reports:
Therapeutic Respiratory
Devices Market Size By Product (Nebulizers, Humidifiers, Oxygen
Concentrators, Ventilators, Gas Analyzers, Capnographs), By Technology
(Electrostatic Filtration, HEPA, Hollow Fiber Filtration, Microsphere
Separation), By Filters (Nebulizer, Humidifier, Positive Airway Pressure
Device, Oxygen Concentrator, Ventilator Filters), Industry Analysis Report,
Regional Outlook (U.S., Canada, Germany, Switzerland, France, Italy, Spain,
China, India, Japan, Brazil, Mexico, South Africa), Application Potential,
Price Trends, Competitive Market Share & Forecast, 2016 – 2024
About Global Market Insights:
Global Market
Insights, Inc., headquartered in Delaware, U.S., is a global market research
and consulting service provider; offering syndicated and custom research
reports along with growth consulting services. Our business intelligence and
industry research reports offer clients with penetrative insights and
actionable market data specially designed and presented to aid strategic
decision making. These exhaustive reports are designed via a proprietary
research methodology and are available for key industries such as chemicals,
advanced materials, technology, renewable energy and biotechnology.
Contact Us:
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://gminsights.wordpress.com
Connect with us: Facebook | Google+ | LinkedIn | Twitter
No comments:
Post a Comment